AUTHOR=Dedulle An , Fitousi Niki , Marshall Nicholas , Bosmans Hilde 

TITLE=Automated size-specific dosimetry for chest posterior–anterior projection radiography

JOURNAL=Frontiers in Physics

VOLUME=Volume 12 - 2024

YEAR=2024

URL=https://www.frontiersin.org/journals/physics/articles/10.3389/fphy.2024.1441316

DOI=10.3389/fphy.2024.1441316

ISSN=2296-424X

ABSTRACT=Chest radiography is a frequently performed examination and therefore accurate patient dosimetry is important. One means of increasing dosimetric accuracy is through the use of size-specific dosimetry and the aim of this work was to determine which patients would benefit from such a methodology applied in chest posterior-anterior (PA) projection radiography. A database of 44 voxel models were created from CT scans, representing adults with BMI from underweight, normal, overweight and obese classes. Monte Carlo simulation was used to generate dose conversion factors for each models. Correlation curves of the dose conversion factors with water equivalent diameter (WED) of the 44 voxel phantoms were obtained. A total of 8536 chest PA examinations acquired between 2015-2019 using three x-ray systems were then retrospectively collected; 4748 men (median age: 61±21years) and 3788 women (median age: 60±23years). The WED of the patients was estimated from the ratio of detector air-kerma to incident air-kerma, using parameters in the DICOM header of the images. For all patients, a size-specific conversion factor was selected automatically using the relation between WED and dose conversion factor determined for the phantoms. The size-specific organ doses and effective doses were calculated based on these conversion factors and size-specific effective dose then compared to the standard effective dose calculation with a paired test. The lung doses ranged from 7µGy to 96µGy and had a good correlation with patient size in terms of WED (p < 0.01, R2 between 0.52 and 0.77). The doses for the thyroid ranged from 2µGy to 42µGy and correlated strongly with the patient size (p < 0.01, R2 between 0.65 and 0.85). Breast doses ranged from 2µGy to 13µGy and the correlation with patient size was weak (p < 0.01, R2 between 0.01 and 0.28). The size-specific effective dose ranged from 4µSv to 42µSv. The difference between the size-specific and standard effective dose ranged from −35% to 69% (p < 0.01), with differences exceeding ±20% for 37% of the cases. In conclusion, the method presented in this study enables automated size-specific dosimetry, within the proposed maximum deviation of ±20%, and should be considered for routine application.